Annual Total Long Term Liabilities
$29.05 M
+$4.18 M+16.81%
01 June 2022
Summary:
Pluristem Therapeutics annual total long term liabilities is currently $29.05 million, with the most recent change of +$4.18 million (+16.81%) on 01 June 2022. During the last 3 years, it has risen by +$4.18 million (+16.81%).PSTI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$27.84 M
-$1.22 M-4.18%
01 September 2022
Summary:
Pluristem Therapeutics quarterly total long term liabilities is currently $27.84 million, with the most recent change of -$1.22 million (-4.18%) on 01 September 2022.PSTI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +16.8% | +13.7% |
| 5 y5 years | +2082.6% | +1163.5% |
PSTI Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -12.3% |
Pluristem Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $27.84 M(-4.2%) |
| June 2022 | $29.05 M(+16.8%) | $29.05 M(-6.8%) |
| Mar 2022 | - | $31.16 M(-1.8%) |
| Dec 2021 | - | $31.75 M(+29.7%) |
| Sept 2021 | - | $24.48 M(-1.6%) |
| June 2021 | $24.87 M(+1622.3%) | $24.87 M(+2116.6%) |
| Mar 2021 | - | $1.12 M(+0.3%) |
| Dec 2020 | - | $1.12 M(-32.5%) |
| Sept 2020 | - | $1.66 M(+14.8%) |
| June 2020 | $1.44 M(+8.5%) | $1.44 M(-12.5%) |
| Mar 2020 | - | $1.65 M(-15.7%) |
| Dec 2019 | - | $1.96 M(-11.1%) |
| Sept 2019 | - | $2.20 M(+65.5%) |
| June 2019 | $1.33 M(-30.1%) | $1.33 M(-28.3%) |
| Mar 2019 | - | $1.86 M(-1.0%) |
| Dec 2018 | - | $1.88 M(-4.6%) |
| Sept 2018 | - | $1.97 M(+3.2%) |
| June 2018 | $1.91 M(+1.9%) | $1.91 M(-1.6%) |
| Mar 2018 | - | $1.94 M(-2.0%) |
| Dec 2017 | - | $1.98 M(+8.6%) |
| Sept 2017 | - | $1.82 M(-2.7%) |
| June 2017 | $1.87 M(-7.0%) | $1.87 M(+4.6%) |
| Mar 2017 | - | $1.79 M(-1.2%) |
| Dec 2016 | - | $1.81 M(-6.4%) |
| Sept 2016 | - | $1.93 M(-3.9%) |
| June 2016 | $2.01 M(-47.5%) | $2.01 M(-2.9%) |
| Mar 2016 | - | $2.07 M(-0.4%) |
| Dec 2015 | - | $2.08 M(-44.1%) |
| Sept 2015 | - | $3.72 M(-2.8%) |
| June 2015 | $3.83 M(-15.0%) | $3.83 M(-1.0%) |
| Mar 2015 | - | $3.87 M(-4.0%) |
| Dec 2014 | - | $4.03 M(-2.9%) |
| Sept 2014 | - | $4.15 M(-7.8%) |
| June 2014 | $4.50 M(-8.6%) | $4.50 M(-9.7%) |
| Mar 2014 | - | $4.99 M(+1.5%) |
| Dec 2013 | - | $4.92 M(-0.9%) |
| Sept 2013 | - | $4.96 M(+0.6%) |
| June 2013 | $4.93 M | $4.93 M(+8.3%) |
| Mar 2013 | - | $4.55 M(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $3.95 M(-1.7%) |
| Sept 2012 | - | $4.02 M(-3.3%) |
| June 2012 | $4.16 M(+621.5%) | $4.16 M(+0.4%) |
| Mar 2012 | - | $4.14 M(-4.0%) |
| Dec 2011 | - | $4.31 M(-4.2%) |
| Sept 2011 | - | $4.50 M(+682.1%) |
| June 2011 | $576.00 K(+60.0%) | $576.00 K(+14.5%) |
| Mar 2011 | - | $503.00 K(+19.8%) |
| Dec 2010 | - | $420.00 K(+4.2%) |
| Sept 2010 | - | $403.00 K(+11.9%) |
| June 2010 | $360.00 K(+57.2%) | $360.00 K(+8.4%) |
| Mar 2010 | - | $332.00 K(+15.3%) |
| Dec 2009 | - | $288.00 K(+16.1%) |
| Sept 2009 | - | $248.00 K(+8.3%) |
| June 2009 | $229.00 K(+25.1%) | $229.00 K(+18.7%) |
| Mar 2009 | - | $193.00 K(-4.5%) |
| Dec 2008 | - | $202.00 K(+3.1%) |
| Sept 2008 | - | $196.00 K(+7.1%) |
| June 2008 | $183.00 K(+88.9%) | $183.00 K(+10.2%) |
| Mar 2008 | - | $166.00 K(-8.8%) |
| Dec 2007 | - | $182.00 K(+16.7%) |
| Sept 2007 | - | $156.00 K(+61.0%) |
| June 2007 | $96.90 K(-97.1%) | $96.90 K(+2.2%) |
| Mar 2007 | - | $94.80 K(+24.4%) |
| Dec 2006 | - | $76.20 K(-97.0%) |
| Sept 2006 | - | $2.54 M(-23.8%) |
| June 2006 | $3.33 M(+811.3%) | $3.33 M(+5466.9%) |
| Mar 2006 | - | $59.90 K(+15.4%) |
| Dec 2005 | - | $51.90 K(-79.8%) |
| Sept 2005 | - | $257.10 K(-29.7%) |
| June 2005 | $365.90 K(-41.8%) | $365.90 K(-77.9%) |
| Mar 2005 | - | $1.65 M(+366.8%) |
| Dec 2004 | - | $354.10 K(-14.9%) |
| Sept 2004 | - | $416.10 K(-33.8%) |
| June 2004 | $628.60 K(+153.3%) | $628.60 K(-55.9%) |
| Mar 2004 | - | $1.43 M(+676.3%) |
| Dec 2003 | - | $183.60 K(-27.3%) |
| Sept 2003 | - | $252.40 K(+1.7%) |
| June 2003 | $248.20 K | $248.20 K |
FAQ
- What is Pluristem Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pluristem Therapeutics?
What is Pluristem Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PSTI is $29.05 M
What is the all time high annual total long term liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual total long term liabilities is $29.05 M
What is Pluristem Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PSTI is $27.84 M
What is the all time high quarterly long term liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly total long term liabilities is $31.75 M